About Wondercel Therapeutics
Wondercel Therapeutics is pioneering REVO-U, a next-generation gene-editing–free universal CAR-T platform that delivers industrial-scale manufacturing, deep clinical responses, and zero GvHD risk — making cell therapy accessible to every patient who needs it.


RevoCAR
CAR-T cells are genetically engineered T cells that express chimeric antigen receptors (CARs). The CAR is a fusion protein consisting of three key components: an antibody-derived extracellular antigen-binding domain, a transmembrane domain, and intracellular signaling domains from the T cell receptor complex.
Committed to pioneering the next generation of CAR-T therapies, we sincerely invite you to join us!
- North Area, Building E, Floors 3-4, Qianhai Shenzhen-Hong Kong Youth Innovation Hub, Nanshan District, Shenzhen, Guangdong Province, China
- 0755-86971801

微信公众号
-
About Us
-
Research & Development
-
News Center
-
Career Development
-
Contact Us
Copyright © 2024 Wondercel Therapeutics Powered by vancheer









